# A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

> **NCT00384475** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 500 (—)

## Conditions studied

- Rhinitis, Allergic, Seasonal
- Hay Fever

## Interventions

- **DRUG:** Ciclesonide Nasal Spray

## Key facts

- **NCT ID:** NCT00384475
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 500 (—)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384475, "A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00384475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*